{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T13:53:22Z","timestamp":1718546002926},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1097\/01.bor.0000229524.97170.83","type":"journal-article","created":{"date-parts":[[2006,5,26]],"date-time":"2006-05-26T08:15:55Z","timestamp":1148631355000},"page":"S21-S27","source":"Crossref","is-referenced-by-count":6,"title":["Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review"],"prefix":"10.1097","volume":"18","author":[{"given":"Steven","family":"Boonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl. 1","key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Osteoporosis: a still increasing prevalence","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/jama.289.15.1957","article-title":"Prevention of hip fractures by external hip protectors: a randomized controlled trial","volume":"289","author":"van Schoor","year":"2003","journal-title":"JAMA"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/01.smj.0000184921.53062.bf","article-title":"Review of treatment modalities for postmenopausal osteoporosis","volume":"98","author":"Hamdy","year":"2005","journal-title":"South Med J"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","article-title":"Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D; RECORD): a randomised placebo-controlled trial","volume":"365","author":"Grant","year":"2005","journal-title":"Lancet"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMcp043801","article-title":"Clinical practice Postmenopausal osteoporosis","volume":"353","author":"Rosen","year":"2005","journal-title":"N Engl J Med"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002230010055","article-title":"Mechanisms of action and therapeutic potential of strontium in bone","volume":"69","author":"Marie","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1359\/jbmr.040906","article-title":"Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats","volume":"19","author":"Ammann","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-5-20210128","first-page":"S19","article-title":"Strontium ranelate reduces the risk of vertebral fracture in postmenopausal women with osteopenia [Abstract]","volume":"15","author":"Sawicki","year":"2004","journal-title":"Osteoporos Int"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.060101","article-title":"Vertebral fracture risk reduction with strontium ranleate in women with postmenopausal osteoporosis is independent of baseline risk factors","volume":"21","author":"Roux","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"Suppl. 3","key":"R16-5-20210128","first-page":"S6","article-title":"Vertebral and nonvertebral antifracture efficacy of strontium ranelate in very elderly women with osteoporosis [Abstract]","volume":"16","author":"Seeman","year":"2005","journal-title":"Osteoporos Int"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2004.52506.x","article-title":"Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old","volume":"52","author":"Boonen","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect on alendronate on risk of fracture in women with low bone density but without vertebral fractures","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jech.44.3.241","article-title":"Incidence of fractures in a geographically defined population","volume":"44","author":"Donaldson","year":"1990","journal-title":"J Epidemiol Commun Health"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s001980050138","article-title":"Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group","volume":"9","author":"Ismail","year":"1999","journal-title":"Osteoporos Int"},{"issue":"Suppl. 3","key":"R23-5-20210128","first-page":"S54","article-title":"Beneficial effects of strontium ranelate on the quality of life in patients with vertebral osteoporosis (SOTI study)","volume":"16","author":"Marquis","year":"2005","journal-title":"Osteoporos Int"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","article-title":"The association of radiographically detected vertebral fractures with back pain and function: a prospective study","volume":"128","author":"Nevitt","year":"1998","journal-title":"Ann Intern Med"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1013041206433","article-title":"Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST","volume":"10","author":"Marquis","year":"2001","journal-title":"Qual Life Res"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1477-7525-3-69","article-title":"Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis","volume":"3","author":"De La Loge","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1742-1241.2001.tb11111.x","article-title":"Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis","volume":"55","author":"Dursun","year":"2001","journal-title":"Int J Clin Pract"},{"key":"R29-5-20210128","first-page":"1579","article-title":"The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women","volume":"30","author":"Oglesby","year":"2003","journal-title":"J Rheumatol"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in western France","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0037-1616243","article-title":"The epidemiology of venous thromboembolism in the community","volume":"86","author":"Heit","year":"2001","journal-title":"Thromb Haemost"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","article-title":"Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis","volume":"21","author":"Cramer","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","article-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women","volume":"80","author":"Recker","year":"2005","journal-title":"Mayo Clin Proc"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.bor.0000229524.97170.83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T14:16:06Z","timestamp":1683468966000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-200606001-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":32,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000229524.97170.83","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}